Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2011, Article ID 256186, 10 pages
http://dx.doi.org/10.1155/2011/256186
Research Article

Consequences of PPARα Invalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids

1INRA, UMR914 Nutrition Physiology and Ingestive Behavior, F-75005 Paris, France
2AgroParisTech, UMR914 Nutrition Physiology and Ingestive Behavior, F-75005 Paris, France
3INRA, UR66 ToxAlim, Laboratoire de Pharmacologie et Toxicologie, Toulouse, France

Received 26 April 2011; Revised 26 June 2011; Accepted 11 July 2011

Academic Editor: Stephane Mandard

Copyright © 2011 Najoua Guelzim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999. View at Google Scholar · View at Scopus
  2. H. Keller, F. Givel, M. Perroud, and W. Wahli, “Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements,” Molecular Endocrinology, vol. 9, no. 7, pp. 794–804, 1995. View at Google Scholar · View at Scopus
  3. P. Lefebvre, G. Chinetti, J.-C. Fruchart, and B. Staels, “Sorting out the roles of PPAR{α} in energy metabolism and vascular homeostasis,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 571–580, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. Mandard, M. Muller, and S. Kersten, “Peroxisome proliferator-activated receptor α target genes,” Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393–416, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. Mandard, R. Stienstra, P. Escher et al., “Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors,” Cellular and Molecular Life Sciences, vol. 64, no. 9, pp. 1145–1157, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Kersten, S. Mandard, P. Escher et al., “The peroxisome proliferator-activated receptor {α} regulates amino acid metabolism,” FASEB Journal, vol. 15, no. 11, pp. 1971–1978, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. Patsouris, S. Mandard, P. J. Voshol et al., “PPARα governs glycerol metabolism,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 94–103, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. Sheikh, G. Camejo, B. Lanne, T. Halvarsson, M. R. Landergren, and N. D. Oakes, “Beyond lipids, pharmacological PPAR{α} activation has important effects on amino acid metabolism as studied in the rat,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 4, pp. E1157–E1165, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. N. Guelzim, F. Mariotti, P. G. Martin, F. Lasserre, T. Pineau, and D. Hermier, “A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis,” Amino Acids. In press. View at Publisher · View at Google Scholar · View at PubMed
  10. D. L. Bella, L. L. Hirschberger, Y. Hosokawa, and M. H. Stipanuk, “Mechanisms involved in the regulation of key enzymes of cysteine metabolism in rat liver in vivo,” American Journal of Physiology—Endocrinology and Metabolism, vol. 276, no. 2, part 1, pp. E326–E335, 1999. View at Google Scholar · View at Scopus
  11. H. J. Forman, H. Zhang, and A. Rinna, “Glutathione: overview of its protective roles, measurement, and biosynthesis,” Molecular Aspects of Medicine, vol. 30, no. 1-2, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. H. Stipanuk, “Role of the liver in regulation of body cysteine and taurine levels: a brief review,” Neurochemical Research, vol. 29, no. 1, pp. 105–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Galinier, A. Carriere, Y. Fernandez et al., “Site specific changes of redox metabolism in adipose tissue of obese Zucker rats,” FEBS Letters, vol. 580, no. 27, pp. 6391–6398, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie, and N. D. Vaziri, “Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome,” Metabolism, vol. 55, no. 7, pp. 928–934, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Song, W. Jia, Y. Yao et al., “Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes,” Clinical Science, vol. 112, no. 12, pp. 599–606, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Giral, N. Jacob, C. Dourmap et al., “Elevated γ-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 3, pp. 587–593, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. C. Blouet, F. Mariotti, D. Azzout-Marniche et al., “Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance,” Free Radical Biology and Medicine, vol. 42, no. 7, pp. 1089–1097, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. K. Jain, T. Velusamy, J. L. Croad, J. L. Rains, and R. Bull, “L-Cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-κB activation in the livers of Zucker diabetic rats,” Free Radical Biology and Medicine, vol. 46, no. 12, pp. 1633–1638, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. T. Toyama, H. Nakamura, Y. Harano et al., “PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats,” Biochemical and Biophysical Research Communications, vol. 324, no. 2, pp. 697–704, 2004. View at Google Scholar
  21. I. Inoue, S. Noji, T. Awata et al., “Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor α is associated with Cu2+, Zn2+-superoxide dismutase in the liver,” Life Sciences, vol. 63, no. 2, pp. 135–144, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Inoue, S. Goto, T. Matsunaga et al., “The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells,” Metabolism, vol. 50, no. 1, pp. 3–11, 2001. View at Google Scholar
  23. M. A. Abdelmegeed, K. H. Moon, J. P. Hardwick, F. J. Gonzalez, and B. J. Song, “Role of peroxisome proliferator-activated receptor-α in fasting-mediated oxidative stress,” Free Radical Biology and Medicine, vol. 47, no. 6, pp. 767–778, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. I. Tkac, A. Molcanyiova, M. Javorsky, and M. Kozarova, “Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity,” Pharmacological Research, vol. 53, no. 3, pp. 261–264, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. S. L. Arnaiz, M. Travacio, A. J. Monserrat, J. C. Cutrin, S. Llesuy, and A. Boveris, “Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate,” Biochimica et Biophysica Acta, vol. 1360, no. 3, pp. 222–228, 1997. View at Publisher · View at Google Scholar
  26. Y. Fang, J. Favre, M. Vercauteren et al., “Reduced cardiac remodelling and prevention of glutathione deficiency after ω-3 supplementation in chronic heart failure,” Fundamental and Clinical Pharmacology, vol. 25, no. 3, pp. 323–332, 2011. View at Publisher · View at Google Scholar · View at PubMed
  27. T. R. Ramaprasad, V. Baskaran, T. P. Krishnakantha, and B. R. Lokesh, “Modulation of antioxidant enzyme activities, platelet aggregation and serum prostaglandins in rats fed spray-dried milk containing n-3 fatty acid,” Molecular and Cellular Biochemistry, vol. 280, no. 1-2, pp. 9–16, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. H. Erdogan, E. Fadillioglu, S. Ozgocmen et al., “Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 3, pp. 149–152, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K. Arab, A. Rossary, F. Flourié, Y. Tourneur, and J. P. Steghens, “Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating γ-glutamyl-cysteinyl ligase and glutathione reductase,” British Journal of Nutrition, vol. 95, no. 1, pp. 18–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Morise, C. Thomas, J. F. Landrier, P. Besnard, and D. Hermier, “Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARα in male and female mice,” European Journal of Nutrition, vol. 48, no. 8, pp. 465–473, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P. G. Martin, H. Guillou, F. Lasserre et al., “Novel aspects of PPARα-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study,” Hepatology, vol. 45, no. 3, pp. 767–777, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S. S. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar · View at Scopus
  33. P. Costet, C. Legendre, J. Moré, A. Edgar, P. Galtier, and T. Pineau, “Peroxisome proliferator-activated receptor α -isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis,” Journal of Biological Chemistry, vol. 273, no. 45, pp. 29577–29585, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Rakhshandehroo, L. M. Sanderson, M. Matilainen et al., “Comprehensive analysis of PPARα-dependent regulation of hepatic lipid metabolism by expression profiling,” PPAR Research, vol. 2007, Article ID 26839, 13 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. N. Chotechuang, D. Azzout-Marniche, C. Bos et al., “mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat,” American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 6, pp. E1313–E1323, 2009. View at Publisher · View at Google Scholar · View at PubMed
  36. T. Santa, C. Aoyama, T. Fukushima, K. Imai, and T. Funatsu, “Suppression of thiol exchange reaction in the determination of reduced-form thiols by high-performance liquid chromatography with fluorescence detection after derivatization with fluorogenic benzofurazan reagent, 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate and 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole,” Biomedical Chromatography, vol. 20, no. 6-7, pp. 656–661, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. C. C. White, H. Viernes, C. M. Krejsa, D. Botta, and T. J. Kavanagh, “Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity,” Analytical Biochemistry, vol. 318, no. 2, pp. 175–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Neschen, K. Morino, J. Dong et al., “n-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-α-dependent manner,” Diabetes, vol. 56, no. 4, pp. 1034–1041, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. E. Hopps, D. Noto, G. Caimi, and M. R. Averna, “A novel component of the metabolic syndrome: the oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 1, pp. 72–77, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. Bunger, G. J. Hooiveld, S. Kersten, and M. Muller, “Exploration of PPAR functions by microarray technology—a paradigm for nutrigenomics,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 1046–1064, 2007. View at Publisher · View at Google Scholar · View at PubMed
  41. A. Pastore, G. Federici, E. Bertini, and F. Piemonte, “Analysis of glutathione: implication in redox and detoxification,” Clinica Chimica Acta, vol. 333, no. 1-2, pp. 19–39, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Tsuboyama-Kasaoka, C. Shozawa, K. Sano et al., “Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity,” Endocrinology, vol. 147, no. 7, pp. 3276–3284, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S. Kalhan, J. Edmison, S. Marczewski et al., “Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine,” Clinical Science, vol. 121, no. 4, pp. 179–189, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. L. Miao and D. K. S. Clair, “Regulation of superoxide dismutase genes: implications in disease,” Free Radical Biology and Medicine, vol. 47, no. 4, pp. 344–356, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. G. Wang, X. Liu, Q. Guo, and S. Namura, “Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels,” Brain Research, vol. 1359, pp. 247–255, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. P. Strazzullo and J. G. Puig, “Uric acid and oxidative stress: relative impact on cardiovascular risk?” Nutrition, Metabolism and Cardiovascular Diseases, vol. 17, no. 6, pp. 409–414, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. B. A. Neuschwander-Tetri, “Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites,” Hepatology, vol. 52, no. 2, pp. 774–788, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. W. V. Berghe, L. Vermeulen, P. Delerive, K. de Bosscher, B. Staels, and G. Haegeman, “A paradigm for gene regulation: inflammation, NF-κB and PPAR,” Advances in Experimental Medicine and Biology, vol. 544, pp. 181–196, 2003. View at Google Scholar · View at Scopus